Olopatadine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C21H23NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D27V6190PM, chemically known as 11-((z)-3-(dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid but generally known as olopatadine, which bears US NIH Compound Identifier 5281071. European Medicines Agency schedules Olopatadine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09431MIG. The term OLOPATADINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, No. 3, 1995, List 35). World Health Organization schedules olopatadine in its Anatomical Therapeutic Chemical (ATC) Classification. OLOPATADINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule olopatadine under HS 29329985 and SITC 51569. As of Q4 2014, OLOPATADINE remains the US FDA Preferred Term for this commodity. Olopatadine bears US NLM identifiers UMLS ID C0527189 and NCI Concept Code C61866. SMILES: O1C2C(/C(=C\CCN(C)C)C3C(C1)CCCC3)CC(CC2)CC(=O)O.